Cover Image
Market Research Report

Global Oncolytic Virus Therapy Market Size, Status and Forecast 2025

Published by QYResearch Product code 606167
Published Content info 136 Pages
Delivery time: 2-3 business days
Price
Back to Top
Global Oncolytic Virus Therapy Market Size, Status and Forecast 2025
Published: February 19, 2018 Content info: 136 Pages
Description

This report studies the Oncolytic Virus Therapy market status and outlook of global and major regions, from angles of players, regions, product types and end industries; this report analyzes the top players in global and major regions, and splits the Oncolytic Virus Therapy market by product type and applications/end industries.

Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn't until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.

For developing product, there are 3 products in Phase 3, 8 products in Phase 2, 7 products in Phase 1 and 3 products in Preclinical. The total investment for Oncolytic Virus Therapy developing is around 84 M USD in 2017.

The major players in global Oncolytic Virus Therapy market include:

  • Amgen
  • Oncolytics Biotech
  • Viralytics
  • Transgene SA
  • Oncolys BioPharma
  • Targovax
  • PsiOxus Therapeutics
  • SillaJen Biotherapeutics
  • Sorrento Therapeutics
  • Lokon Pharma
  • Genelux Corporation
  • Vyriad
  • TILT Biotherapeutics
  • Cold Genesys

Geographically, this report is segmented into several key regions, with market size and R&D investment, market share and growth rate of Oncolytic Virus Therapy in these regions, from 2013 to 2025 (forecast), covering:

  • North America
  • Europe
  • Asia-Pacific

On the basis on the end users/applications, this report covers:

  • Melanoma
  • Prostate Cancer
  • Breast Cancer
  • Ovarian Cancer
  • Others
Table of Contents

Table of Contents

1 Oncolytic Virus Therapy Market Overview

  • 1.1 Oncolytic Virus Therapy Product Overview
  • 1.2 Oncolytic Virus Therapy Market by Pipeline
  • 1.3 Oncolytic Virus Therapy Segment by Application
    • 1.3.1 Global Oncolytic Virus Therapy R&D Investment and Growth Rate Comparison by Application (2013-2025)
    • 1.3.2 Global Oncolytic Virus Therapy R&D Investment Market Share by Application in 2017
    • 1.3.3 Prostate Cancer
    • 1.3.4 Melanoma
    • 1.3.5 Breast Cancer
    • 1.3.6 Ovarian Cancer
  • 1.4 Global Oncolytic Virus Therapy Market by Regions (2013-2018)
    • 1.4.1 Global Oncolytic Virus Therapy Market Size and Growth Rate Comparison by Regions (2013-2025)
    • 1.4.2 North America Oncolytic Virus Therapy Status and Prospect (2013-2025)
    • 1.4.3 Europe Oncolytic Virus Therapy Status and Prospect (2013-2025)
    • 1.4.4 Asia Pacific Oncolytic Virus Therapy Status and Prospect (2013-2025)
  • 1.5 Global Oncolytic Virus Therapy Market Size (2013-2025)

2 Global Oncolytic Virus Therapy Market Competition by Manufacturers

  • 2.1 Global Oncolytic Virus Therapy Pipeline of Key Players/Manufacturers
  • 2.2 Global Oncolytic Virus Therapy R&D Investment and Share by Manufacturers (2016-2017)
  • 2.3 Manufacturers Oncolytic Virus Therapy Headquarters, Established Date, Product Types
  • 2.4 Oncolytic Virus Therapy Market Competitive Situation and Trends
    • 2.4.1 Oncolytic Virus Therapy R&D Investment Concentration Rate
    • 2.4.2 Oncolytic Virus Therapy R&D Investment Share of Top 3 and Top 5 Manufacturers
    • 2.4.3 Mergers & Acquisitions, Expansion

3 Global Oncolytic Virus Therapy R&D Investment by Regions (2013-2018)

  • 3.1 Global Oncolytic Virus Therapy Developer Distribution by Regions
  • 3.2 Global Oncolytic Virus Therapy R&D Investment and Market Share by Regions (2013-2018)
  • 3.3 Global Oncolytic Virus Therapy R&D Investment and Growth Rate (2013-2018)
  • 3.4 North America Oncolytic Virus Therapy R&D Investment and Growth Rate (2013-2018)
  • 3.5 Europe Oncolytic Virus Therapy R&D Investment and Growth Rate (2013-2018)
  • 3.6 Asia Pacific Oncolytic Virus Therapy R&D Investment and Growth Rate (2013-2018)

4 Global Oncolytic Virus Therapy Market Size by Regions (2013-2018)

  • 4.1 Global Oncolytic Virus Therapy Consumption by Regions (2013-2018)
  • 4.2 North America Oncolytic Virus Therapy Market Size (2013-2018)
  • 4.3 Europe Oncolytic Virus Therapy Market Size (2013-2018)
  • 4.4 Asia Pacific Oncolytic Virus Therapy Market Size (2013-2018)

5 Global Oncolytic Virus Therapy R&D Investment by Application

  • 5.1 Global Oncolytic Virus Therapy Investment by Application (2013-2018)
  • 5.2 Global Oncolytic Virus Therapy Market Size by Application (2013-2018)

6 Analysis of Oncolytic Virus Therapy Industry Key Manufacturers

  • 6.1 Amgen
    • 6.1.1 Company Profile
    • 6.1.2 Product Information
    • 6.1.3 R&D Investment, Product and Stage
  • 6.2 Oncolytics Biotech
    • 6.2.1 Company Profile
    • 6.2.2 Product Information
    • 6.2.3 R&D Investment, Product and Stage
  • 6.3 Viralytics
    • 6.3.1 Company Profile
    • 6.3.2 Product Information
    • 6.3.3 R&D Investment, Product and Stage
  • 6.4 Transgene SA
    • 6.4.1 Company Profile
    • 6.4.2 Product Information
    • 6.4.3 R&D Investment, Product and Stage
  • 6.5 Oncolys BioPharma
    • 6.5.1 Company Profile
    • 6.5.2 Product Information
    • 6.5.3 R&D Investment, Product and Stage
  • 6.6 Targovax
    • 6.6.1 Company Profile
    • 6.6.2 Product Information
    • 6.6.3 R&D Investment, Product and Stage
  • 6.7 PsiOxus Therapeutics
    • 6.7.1 Company Profile
    • 6.7.2 Product Information
    • 6.7.3 R&D Investment, Product and Stage
  • 6.8 SillaJen Biotherapeutics
    • 6.8.1 Company Profile
    • 6.8.2 Product Information
    • 6.8.3 R&D Investment, Product and Stage
  • 6.9 Sorrento Therapeutics
    • 6.9.1 Company Profile
    • 6.9.2 Product Information
    • 6.9.3 R&D Investment, Product and Stage
  • 6.10 Lokon Pharma
    • 6.10.1 Company Profile
    • 6.10.2 Product Information
    • 6.10.3 R&D Investment, Product and Stage
  • 6.11 Genelux Corporation
    • 6.11.1 Company Profile
    • 6.11.2 Product Information
    • 6.11.3 R&D Investment, Product and Stage
  • 6.12 Vyriad
    • 6.12.1 Company Profile
    • 6.12.2 Product Information
    • 6.12.3 R&D Investment, Product and Stage
  • 6.13 TILT Biotherapeutics
    • 6.13.1 Company Profile
    • 6.13.2 Product Information
    • 6.13.3 R&D Investment, Product and Stage
  • 6.14 Cold Genesys
    • 6.14.1 Company Profile
    • 6.14.2 Product Information
    • 6.14.3 R&D Investment, Product and Stage

7 New Drugs Manufacturing Cost Analysis

  • 7.1 New Drugs R&D Cost Analysis
    • 7.1.1 Clinical Phase Costs
    • 7.1.2 Capitalized Costs
  • 7.2 Proportion of Manufacturing Cost Structure
    • 7.2.1 Raw Materials
    • 7.2.2 Labor Cost
      • 7.2.2.1 USA Labor Cost Analysis
      • 7.2.2.2 Europe Labor Costs Analysis
      • 7.2.2.3 Asia Labor Costs Analysis
    • 7.2.3 Manufacturing Expenses
  • 7.3 Manufacturing Process Analysis of Oncolytic Virus Therapy

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

  • 8.1 Oncolytic Virus Therapy Industrial Chain Analysis
  • 8.2 Upstream Raw Materials Sourcing
  • 8.3 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

  • 9.1 Marketing Channel
    • 9.1.1 Direct Marketing
    • 9.1.2 Indirect Marketing
    • 9.1.3 Marketing Channel Development Trend
  • 9.2 Market Positioning
    • 9.2.1 Pricing Strategy
    • 9.2.2 Brand Strategy
    • 9.2.3 Target Client
  • 9.3 Distributors/Traders List

10 Market Effect Factors Analysis

  • 10.1 Technology Progress/Risk
    • 10.1.1 Substitutes Threat
    • 10.1.2 Cancer Patients Analysis
  • 10.2 Consumer Needs/Customer Preference Change
  • 10.3 Economic/Political Environmental Change

11 Global Oncolytic Virus Therapy Market Forecast (2018-2025)

  • 11.1 Global Oncolytic Virus Therapy R&D Investment and Market Size Forecast
    • 11.1.1 Global Oncolytic Virus Therapy R&D Investment and Growth Rate Forecast (2018-2025)
    • 11.1.2 Global Oncolytic Virus Therapy Market Size and Growth Rate Forecast (2018-2025)
  • 11.2 Global Oncolytic Virus Therapy R&D Investment Forecast by Regions (2018-2025)
    • 11.2.1 North America Oncolytic Virus Therapy R&D Investment Forecast (2018-2025)
    • 11.2.2 Europe Oncolytic Virus Therapy R&D Investment Forecast (2018-2025)
    • 11.2.3 Asia Pacific Oncolytic Virus Therapy R&D Investment Forecast (2018-2025)
  • 11.3 Global Oncolytic Virus Therapy Market Size Forecast by Regions (2018-2025)
    • 11.3.1 North America Oncolytic Virus Therapy Market Size Forecast (2018-2025)
    • 11.3.2 Europe Oncolytic Virus Therapy Market Size Forecast (2018-2025)
    • 11.3.3 Asia Pacific Oncolytic Virus Therapy Market Size Forecast (2018-2025)
  • 11.4 Global Oncolytic Virus Therapy R&D Investment Forecast by Application (2018-2025)
  • 11.5 Global Oncolytic Virus Therapy Market Size Forecast by Application (2018-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

  • 13.1 Methodology/Research Approach
    • 13.1.1 Research Programs/Design
    • 13.1.2 Market Size Estimation
    • 13.1.3 Market Breakdown and Data Triangulation
  • 13.2 Data Source
    • 13.2.1 Secondary Sources
    • 13.2.2 Primary Sources
  • 13.3 Disclaimer
  • 13.4 Author List

List of Tables and Figures

  • Figure Product Picture of Oncolytic Virus Therapy
  • Table Oncolytic Virus Therapy Market by Pipeline
  • Table Global Oncolytic Virus Therapy R&D Investment (K USD) and Growth Rate Comparison by Application (2013-2025)
  • Figure Global Oncolytic Virus Therapy R&D Investment Market Share by Application in 2017
  • Figure Prostate Cancer Examples
  • Figure Melanoma Examples
  • Figure Breast Cancer Examples
  • Figure Ovarian Cancer Examples
  • Figure Global Oncolytic Virus Therapy Market Size (K USD) Comparison and Growth Rate by Regions (2013-2025)
  • Table Oncolytic Virus Therapy Market Size (K USD) Comparison by Regions (2013-2025)
  • Figure North America Oncolytic Virus Therapy Market Size (K USD) and Growth Rate (2013-2025)
  • Figure Europe Oncolytic Virus Therapy Revenue (M USD) and Growth Rate (2013-2025)
  • Figure Asia Pacific Oncolytic Virus Therapy Revenue (M USD) and Growth Rate (2013-2025)
  • Figure Global Oncolytic Virus Therapy Market Size (K USD) Status and Outlook (2013-2025)
  • Table Global Oncolytic Virus Therapy Pipeline of Key Players/Manufacturers
  • Table Global Oncolytic Virus Therapy R&D Investment (K USD) of Key Manufacturers (2016-2017)
  • Table Global Oncolytic Virus Therapy R&D Investment Share by Manufacturers (2016-2017)
  • Figure 2016 Oncolytic Virus Therapy R&D Investment Share by Manufacturers
  • Figure 2017 Oncolytic Virus Therapy R&D Investment Share by Manufacturers
  • Table Manufacturers Oncolytic Virus Therapy Headquarters and Established Date
  • Table Manufacturers Oncolytic Virus Therapy Product Category
  • Figure 2017 Oncolytic Virus Therapy R&D Investment Share by Manufacturers
  • Figure Oncolytic Virus Therapy R&D Investment Share of Top 3 Manufacturers
  • Figure Oncolytic Virus Therapy R&D Investment Share of Top 5 Manufacturers
  • Table Mergers & Acquisitions, Expansion
  • Table Global Oncolytic Virus Therapy Developer Distribution by Regions in 2017
  • Table Global Oncolytic Virus Therapy R&D Investment (K USD) by Regions (2013-2018)
  • Table Global Oncolytic Virus Therapy R&D Investment Market Share by Regions (2013-2018)
  • Figure Global Oncolytic Virus Therapy R&D Investment Market Share by Regions (2013-2018)
  • Figure 2017 Global Oncolytic Virus Therapy R&D Investment Market Share by Regions
  • Figure Global Oncolytic Virus Therapy R&D Investment (K USD) and Growth Rate (2013-2018)
  • Figure North America Oncolytic Virus Therapy R&D Investment (K USD) and Growth Rate (2013-2018)
  • Figure Europe Oncolytic Virus Therapy R&D Investment (K USD) and Growth Rate (2013-2018)
  • Figure Asia Pacific Oncolytic Virus Therapy R&D Investment (K USD) and Growth Rate (2013-2018)
  • Table Global Oncolytic Virus Therapy Market Size (K USD) by Regions (2013-2018)
  • Table Global Oncolytic Virus Therapy Consumption Market Share by Regions (2013-2018)
  • Figure Global Oncolytic Virus Therapy Consumption Market Share by Regions (2013-2018)
  • Figure 2017 Global Oncolytic Virus Therapy Consumption Market Share by Regions
  • Figure North America Oncolytic Virus Therapy Market Size (K USD) and Growth Rate (2013-2018)
  • Figure Europe Oncolytic Virus Therapy Market Size (K USD) and Growth Rate (2013-2018)
  • Figure Asia Pacific Oncolytic Virus Therapy Market Size (K USD) and Growth Rate (2013-2018)
  • Table Global Oncolytic Virus Therapy R&D Investment (K USD) by Application (2013-2018)
  • Table Global Oncolytic Virus Therapy R&D Investment Share by Application (2013-2018)
  • Figure R&D Investment Market Share of Oncolytic Virus Therapy by Application (2013-2018)
  • Figure 2013 R&D Investment Market Share of Oncolytic Virus Therapy by Application
  • Figure 2017 R&D Investment Market Share of Oncolytic Virus Therapy by Application
  • Table Global Oncolytic Virus Therapy Market Size (K USD) by Application (2013-2018)
  • Table Amgen Company Profile
  • Figure Oncolytic Virus Therapy Product Picture of Amgen
  • Table Oncolytic Virus Therapy R&D Investment (K USD), Product and Stage of Amgen 2016-2017
  • Table Oncolytics Biotech Company Profile
  • Figure Oncolytic Virus Therapy Product Picture of Oncolytics Biotech
  • Table Oncolytic Virus Therapy R&D Investment (K USD), Product and Stage of Oncolytics Biotech 2016-2017
  • Table Viralytics Company Profile
  • Figure Oncolytic Virus Therapy Product Picture of Viralytics
  • Table Oncolytic Virus Therapy R&D Investment (K USD), Product and Stage of Viralytics 2016-2017
  • Table Transgene SA Company Profile
  • Figure Oncolytic Virus Therapy Product Picture of Transgene SA
  • Table Oncolytic Virus Therapy R&D Investment (K USD), Product and Stage of Transgene SA 2016-2017
  • Table Oncolys BioPharma Company Profile
  • Figure Oncolytic Virus Therapy Product Picture of Oncolys BioPharma
  • Table Oncolytic Virus Therapy R&D Investment (K USD), Product and Stage of Oncolys BioPharma 2016-2017
  • Table Targovax Company Profile
  • Figure Oncolytic Virus Therapy Product Picture of Targovax
  • Table Oncolytic Virus Therapy R&D Investment (K USD), Product and Stage of Targovax 2016-2017
  • Table PsiOxus Therapeutics Company Profile
  • Figure Oncolytic Virus Therapy Product Picture of PsiOxus Therapeutics
  • Table Oncolytic Virus Therapy R&D Investment (K USD), Product and Stage of PsiOxus Therapeutics 2016-2017
  • Table SillaJen Biotherapeutics Company Profile
  • Figure Oncolytic Virus Therapy Product Picture of SillaJen Biotherapeutics
  • Table Oncolytic Virus Therapy R&D Investment (K USD), Product and Stage of SillaJen Biotherapeutics 2016-2017
  • Table Sorrento Therapeutics Company Profile
  • Figure Oncolytic Virus Therapy Product Picture of Sorrento Therapeutics
  • Table Oncolytic Virus Therapy R&D Investment (K USD), Product and Stage of Sorrento Therapeutics 2016-2017
  • Table Lokon Pharma Company Profile
  • Figure Oncolytic Virus Therapy Product Picture of Lokon Pharma
  • Table Oncolytic Virus Therapy R&D Investment (K USD), Product and Stage of Lokon Pharma 2016-2017
  • Table Genelux Corporation Company Profile
  • Figure Oncolytic Virus Therapy Product Picture of Genelux Corporation
  • Table Oncolytic Virus Therapy R&D Investment (K USD), Product and Stage of Genelux Corporation 2016-2017
  • Table Vyriad Company Profile
  • Figure Oncolytic Virus Therapy Product Picture of Vyriad
  • Table Oncolytic Virus Therapy R&D Investment (K USD), Product and Stage of Vyriad 2016-2017
  • Table TILT Biotherapeutics Company Profile
  • Figure Oncolytic Virus Therapy Product Picture of TILT Biotherapeutics
  • Table Oncolytic Virus Therapy R&D Investment (K USD), Product and Stage of TILT Biotherapeutics 2016-2017
  • Table Cold Genesys Company Profile
  • Figure Oncolytic Virus Therapy Product Picture of Cold Genesys
  • Table Oncolytic Virus Therapy R&D Investment (K USD), Product and Stage of Cold Genesys 2016-2017
  • Figure typical phases from research to the market for a drug candidate
  • Figure Timeline and Development Stages for a Pharmaceutical Products (Industry Average)
  • Table Out-of-pocket Preclinical and Clinical Period Cost per Investigational Biopharmaceutical Compound
  • Table Capitalized Preclinical and Clinical Period costs per Investigational Biopharmaceutical Compound
  • Figure Manufacturing Cost Structure of New Drugs
  • Figure Assessment of API Manufacturing Cost By Region
  • Figure USA Overview of Average Hourly Wages 2015-2016 (USD/Hour)
  • Figure USA Overview of Labor Costs 2013-2016 (110 Index Points)
  • Figure Cost of Employing a Factory Worker
  • Figure 2015 Estimated Labor Costs for the Whole Economy in Europe
  • Figure Monthly Minimum Wages in Asia 2016
  • Figure China Overview of Average Yearly Wages 2015-2016 (CNY/Year)
  • Figure Japan Overview of Average Monthly Wages 2015-2016(JPY Thousand/Month)
  • Table 2015 Global Electricity Price of Industry (USD/KWh) by Country
  • Figure Manufacturing Process Analysis of Oncolytic Virus Therapy
  • Figure Oncolytic Virus Therapy Industrial Chain Analysis
  • Table Major Buyers of Oncolytic Virus Therapy
  • Figure Setting Pricing Policy
  • Table Distributors/Traders List
  • Figure Cancer Incidence by Country in 2016
  • Figure Cancer Mortality by Country in 2016
  • Figure USA numbers of new cancer cases for 2016
  • Figure Global GDP Growth Rate for 2016
  • Figure US GDP 2006-2016 (Billion USD)
  • Figure US CPI Change 2016-2017
  • Figure EU GDP 2006-2016 (Billion USD)
  • Figure EU CPI Change 2012-2016
  • Figure Germany GDP 2006-2016 (Billion USD)
  • Figure Germany CPI Change 2016-2017
  • Figure UK GDP 2006-2016 (Billion USD)
  • Figure UK CPI Change 2016-2017
  • Figure Italy GDP 2006-2016 (Billion USD)
  • Figure Italy CPI Change 2016-2017
  • Figure Japan GDP 2006-2016 (Billion USD)
  • Figure Japan CPI Change 2012-2016
  • Figure China GDP 2006-2016 (Billion USD)
  • Figure China CPI Change 2016-2017
  • Figure Global Oncolytic Virus Therapy R&D Investment (K USD) and Growth Rate Forecast (2018-2025)
  • Figure Global Oncolytic Virus Therapy Market Size (K USD) and Growth Rate Forecast (2018-2025)
  • Table Global Oncolytic Virus Therapy R&D Investment (K USD) Forecast by Regions (2018-2025)
  • Table Global Oncolytic Virus Therapy R&D Investment Market Share Forecast by Regions (2018-2025)
  • Figure Global Oncolytic Virus Therapy R&D Investment Market Share Forecast by Regions (2018-2025)
  • Figure North America Oncolytic Virus Therapy R&D Investment (K USD) and Growth Rate Forecast (2018-2025)
  • Figure Europe Oncolytic Virus Therapy R&D Investment (K USD) and Growth Rate Forecast (2018-2025)
  • Figure Asia Pacific Oncolytic Virus Therapy R&D Investment (K USD) and Growth Rate Forecast (2018-2025)
  • Table Global Oncolytic Virus Therapy Market Size (K USD) Forecast by Regions (2018-2025)
  • Figure Global Oncolytic Virus Therapy Market Size Share Forecast by Regions (2018-2025)
  • Figure North America Oncolytic Virus Therapy Market Size (K USD) and Growth Rate Forecast (2018-2025)
  • Figure Europe Oncolytic Virus Therapy Market Size (K USD) and Growth Rate Forecast (2018-2025)
  • Figure Asia Pacific Oncolytic Virus Therapy Market Size (K USD) and Growth Rate Forecast (2018-2025)
  • Table Global Oncolytic Virus Therapy R&D Investment (K USD) Forecast by Application (2018-2025)
  • Table Global Oncolytic Virus Therapy R&D Investment Share Forecast by Type (2018-2025)
  • Figure Global Oncolytic Virus Therapy R&D Investment Share Forecast by Type (2018-2025)
  • Table Global Oncolytic Virus Therapy Market Size (K USD) Forecast by Application (2018-2025)
  • Table Global Oncolytic Virus Therapy Market Size Share Forecast by Application (2018-2025)
  • Figure Global Oncolytic Virus Therapy Consumption Forecast by Application (2018-2025)
  • Table Research Programs/Design for This Report
  • Figure Bottom-up and Top-down Approaches for This Report
  • Figure Data Triangulation
  • Table Key Data Information from Secondary Sources
  • Table Key Data Information from Primary Sources
Back to Top